Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6SP6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,901
Award facts
- Contract value 100% obligated
- $51,900.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $51,900.88 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zepbound 15 mg/0.5 mL pen injections. This firm fixed-price contract, which is set to be completed by January 29, 2026, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with no set-aside designation applied to this award.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was selected through full and open competition to fulfill this requirement. The company's extensive federal contract portfolio demonstrates its capability to meet the Defense Health Agency's pharmaceutical supply needs across multiple therapeutic domains. Zepbound, a glucagon-like peptide-1 (GLP-1) receptor agonist used for weight management, reflects the broad range of specialty medications supplied through the DLA Troop Support Medical contract vehicle to support military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F6SP6?
SPE2DR26F6SP6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F6SP6 worth?
The government has obligated $51,901 on SPE2DR26F6SP6.
Is contract SPE2DR26F6SP6 an order under another contract?
Yes. SPE2DR26F6SP6 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SP6 competed?
The extent of competition for SPE2DR26F6SP6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award